Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Ascentage Pharma Group International (36X.F)

5.05
+0.29
+(6.09%)
As of 9:59:02 AM GMT+2. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
903,029
221,984
209,711
27,910
12,450
Cost of Revenue
27,448
30,543
21,998
3,328
1,966
Gross Profit
875,581
191,441
187,713
24,582
10,484
Operating Expense
1,201,113
1,064,077
1,037,523
894,417
674,425
Operating Income
-325,532
-872,636
-849,810
-869,835
-663,941
Net Non Operating Interest Income Expense
-41,684
-63,648
-43,058
-9,625
-1,037
Pretax Income
-370,364
-932,862
-887,172
-832,249
-675,448
Tax Provision
-9,827
-7,150
-4,248
-49,825
2,158
Net Income Common Stockholders
-360,285
-925,637
-882,924
-782,424
-677,606
Diluted NI Available to Com Stockholders
-360,285
-925,637
-882,924
-782,424
-677,606
Basic EPS
-1.25
-3.28
-3.35
-3.07
-3.14
Diluted EPS
-1.26
-3.28
-3.35
-3.07
-3.14
Basic Average Shares
290,898.92
282,299.27
263,668.83
254,615.32
215,909.15
Diluted Average Shares
293,035.02
282,299.27
263,668.83
254,615.32
215,909.15
Total Expenses
1,228,561
1,094,620
1,059,521
897,745
676,391
Net Income from Continuing & Discontinued Operation
-360,285
-925,637
-882,924
-782,424
-677,606
Normalized Income
-359,608.44
-927,746.98
-894,602.32
-839,459.44
-674,797.25
Interest Income
35,730
32,409
9,727
7,106
5,218
Interest Expense
77,414
96,057
52,785
16,731
6,255
Net Interest Income
-41,684
-63,648
-43,058
-9,625
-1,037
EBIT
-292,950
-836,805
-834,387
-815,518
-669,193
EBITDA
-292,950
-743,610
-771,472
-787,192
-641,771
Reconciled Cost of Revenue
27,448
30,543
21,998
3,328
1,966
Reconciled Depreciation
--
93,195
62,915
28,326
27,422
Net Income from Continuing Operation Net Minority Interest
-360,285
-925,637
-882,924
-782,424
-677,606
Total Unusual Items Excluding Goodwill
-695
2,127
11,737
60,676
-3,745
Total Unusual Items
-695
2,127
11,737
60,676
-3,745
Normalized EBITDA
-292,255
-745,737
-783,209
-847,868
-638,026
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-18.44
17.02
58.69
3,640.56
-936.25
12/31/2020 - 12/20/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2160.T GNI Group Ltd.
2,200.00
+0.46%
 
GYRE Gyre Therapeutics, Inc.
8.64
+2.86%
 
IMAB I-Mab
0.8304
-2.88%
 
ERAS Erasca, Inc.
1.3800
+11.29%
 
PULM Pulmatrix, Inc.
6.31
+2.44%
 
OLMA Olema Pharmaceuticals, Inc.
4.9600
+4.42%
 
LEGN Legend Biotech Corporation
34.48
+6.95%
 
ONC BeiGene, Ltd.
252.77
+10.27%
 
APLS Apellis Pharmaceuticals, Inc.
17.37
-3.66%
 
IBRX ImmunityBio, Inc.
2.6900
+7.17%